期刊文献+

PDCA循环法提高癌症爆发性疼痛解救剂量合理率的实践 被引量:2

PDCA cycle in improving the reasonable rate of rescue doses for cancer breakthrough pain
原文传递
导出
摘要 目的确保使用吗啡缓释片或羟考酮缓释片的癌痛患者爆发性疼痛(breakthrough pain,BTP)解救剂量合理。方法依循PDCA循环法步骤,分析总结导致BTP解救剂量不合理的原因,根据原因制定解决方案,予以实施。通过点评BTP解救医嘱和收集临床反馈,对方案进行评价和处理。结果经过两轮PDCA循环,完善了方案,可显著提高BTP解救剂量合理率和解救治疗效果。结论 PDCA循环法促进临床合理治疗BTP有积极的意义。 Objective To ensure the reasonable rescue doses for cancer breakthrough pain (BTP) in cancer patients treated with morphine sustained-release tablets or oycodone controlled-release tablets. Methods Following the PDCA cycle, the errors of rescue doses for BTP were analyzed, and countermeasures were set according the reasons and were implemented. We evaluated the countermeasures through reviewing the BTP rescue medication orders and collected clinical feedbacks. Results The countermeasure were optimized after two rounds of PDCA implementations. The reasonable rate of rescue doses for cancer BTP and the effect of rescue treatment were improved significangtly. Conclusion PDCA cycle had positive effect on the clinical rational treatment of BTP.
出处 《中南药学》 CAS 2017年第11期1646-1650,共5页 Central South Pharmacy
关键词 PDCA循环法 爆发性疼痛 解救剂量 PDCA cycle breakthrough pain rescue dose
  • 相关文献

参考文献6

二级参考文献93

  • 1晁青,张亚婷,袁鸿琴,曹兰芳,罗丽红,李维.1例胸膜间皮瘤患者爆发性疼痛的护理[J].现代肿瘤医学,2007,15(2):297-297. 被引量:2
  • 2Elliott A M,Smith B H,Penny K I,et al.The epidemiology of chronic pain in the community[J].Lancet,1999,354(9186):1248-1252.
  • 3International Narcotics Control Board.Report of the international narcotics control board for 2007[EB/OL].(2008-05-05)[2009-09-10].http://www.ebookee.net/Report-of-the-International-Narcotics-Control-Board-for-2007-dl/.
  • 4Hamunen K,Laitinen-Parkkonen P,Paakkari P,et al.What do different databases tell about the use of opioids in seven European countries in 2002?[J].Eur J Pain,2008,12(6):705-715.
  • 5Stjernsward J.WHO cancer pain relief programme[J].Cancer Surv,1988,7(1):195-208.
  • 6Stjernsward J,Colleau S M,Ventafridda V.The World Health Organization Cancer Pain and Palliative Care Program.Past,present,and future[J].J Pain Symptom Manag,1996,12(2):65-72.
  • 7Holthe M,Rakvg T N,Klepstad P,et al.Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene:identification of 10 novel single nucleotide poly-morphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients[J].Pharmacogenomics J,2003,3(1):17-26.
  • 8Rouguieg K,Picard N,Sauvage F L,et al.Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes[J].Drug Metab Dispos,2010,38(1):40-45.
  • 9Klepstad P,Rakvag T T,Kaasa S,et al.The 118 A 》 G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease[J].Acta Anaesthesiol Scand,2004,48(10):1232-1239.
  • 10Rakvg T T,Klepstad P,Baar C,et al.The Val158Met poly-morphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients[J].Pain,2005,116(1-2):73-78.

共引文献82

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部